Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus

Nature Clinical Practice Rheumatology

Volumn 4, Issue 7, 2008, Pages 352-353

  Pan, Hai Feng ^a   Ye, Dong Qing ^a   Li, Xiang Pei ^a  

^a ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERFERON ANTAGONIST; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG DESIGN; DRUG TARGETING; HELPER CELL; IMMUNOPATHOLOGY; INFLAMMATION; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; HUMANS; INTERLEUKIN-17; LUPUS ERYTHEMATOSUS, SYSTEMIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 47149116300     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0815     Document Type: Article

References (14)

1. Cook HT and Botto M (2006) Mechanisms of Disease: The complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2: 330-337
2. Datta SK et al. (2005) T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens. J Mol Med 83: 267-278
3. Kikly K et al. (2006) The IL-23/Th(17) axis: Therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18: 670-675
4. Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5: 521-531
5. Kramer JM and Gaffen SL (2007) Interleukin-17: A new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 78: 1083-1093
6. Nakae S et al. (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173-6177
7. Lubberts E et al. (2004) Treatment with a neutralizing anti-murine intedeuldn-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50: 650-659
8. McGeachy MJ et al. (2007) TGF-betaand IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8: 1390-1397
9. Huber AK et al. (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for graves' ophthalmopathy: The IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93: 1077-1088
10. Wong CK et al. (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus, Lupus 9: 589-593
11. Dong G et al. (2003) IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in luptis nephritis patients. Chin Med J(Engl) 116: 543-548
12. Hsu HC et al. (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9: 166-176
13. Mangini AJ et al. (2007) Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus. Ann N Y Acad Sci 1108: 11-23
14. Korn T et al. (2007) Th17 cells: Effector T cells with inflammatory properties. Semin Immunol 19: 362-371